Pages that link to "Q35360056"

The following pages link to Long term effect of alpha interferon in children with chronic hepatitis B. (Q35360056):

Displaying 40 items.

• KASL clinical practice guidelines: management of chronic hepatitis B (Q26752475) (← links)
• Management of patients with hepatitis B in special populations (Q27016136) (← links)
• Viral hepatitis B and C in children (Q27473273) (← links)
• Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (Q30391932) (← links)
• Hepatitis B in childhood: An update for the paediatrician (Q33588605) (← links)
• Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha (Q33867947) (← links)
• Management of chronic hepatitis B and C virus infections (Q34584886) (← links)
• Drug treatment of pediatric chronic hepatitis B. (Q34661817) (← links)
• Management of chronic hepatitis B. (Q35068048) (← links)
• Pediatric issues in new therapies for hepatitis B and C (Q35122558) (← links)
• Treatment of chronic hepatitis B in children (Q35621745) (← links)
• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States (Q35689607) (← links)
• KASL Clinical Practice Guidelines: Management of chronic hepatitis B. (Q36153966) (← links)
• Treatment options for chronic hepatitis B and C infection in children (Q36607394) (← links)
• Future prospectives for the management of chronic hepatitis B. (Q36841719) (← links)
• Management of chronic hepatitis B: consensus guidelines (Q36849343) (← links)
• Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies (Q37278061) (← links)
• Natural history and clinical management of chronic hepatitis B virus infection in children (Q37278090) (← links)
• Interferons and their use in persistent viral infections (Q37338989) (← links)
• Hepatitis B therapy in children (Q37390647) (← links)
• Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial (Q37420069) (← links)
• Pediatric hepatitis B treatment (Q37666967) (← links)
• Treatment of viral hepatitis B in children (Q37702241) (← links)
• The Rate of Conversion from Immune-tolerant Phase to Early Immune-clearance Phase in Children with Chronic Hepatitis B Virus Infection. (Q37709066) (← links)
• Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future (Q37754603) (← links)
• Antiviral therapy for hepatitis B in special populations (Q37819694) (← links)
• Chronic hepatitis B in children and adolescents: epidemiology and management (Q38093134) (← links)
• Treatment of children with chronic viral hepatitis: what is available and what is in store (Q38127616) (← links)
• Management of chronic hepatitis B infection (Q38210526) (← links)
• Management of chronic hepatitis B in children: an unresolved issue (Q38215076) (← links)
• Hepatitis B virus infection in children (Q38365905) (← links)
• Current antiviral therapies for chronic hepatitis B. (Q40096242) (← links)
• Lamivudine-interferon combination therapy for chronic hepatitis B: further support but no conclusive evidence (Q43760712) (← links)
• Combination and newer therapies for chronic hepatitis B. (Q44242919) (← links)
• Chronic hepatitis B virus (HBV) infection in children: 25 years' experience (Q45352194) (← links)
• Hepatitis B in pregnant women and children (Q46188052) (← links)
• Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. (Q46914193) (← links)
• The influence of interferon-alpha and combination interferon-alpha and lamivudine therapy on height and weight in children with chronic hepatitis B infection (Q47279228) (← links)
• 4. Österreichischer Konsensusbericht zur Diagnose und Therapie der Hepatitis B 2009 (Q57168171) (← links)
• Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B: A long-term follow-up cohort study from China (Q92495056) (← links)